Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov record for the setmelanotide Phase 2 study is displayed with detailed trial information, including participant criteria, treatment cohorts, outcome measures, locations, and study documents.
    Difference
    92%
    Check dated 2026-11-07T11:41:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study page remains inaccessible with a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T11:40:48.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T11:37:26.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T13:35:26.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T13:19:54.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 error, replacing the detailed study information with a simple error page.
    Difference
    20%
    Check dated 2026-09-19T18:28:39.000Z thumbnail image

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.